We are live on ! Find out more
SPRO icon

Spero Therapeutics
SPRO

61 hedge funds and large institutions have $104M invested in Spero Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 11

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 59 → 61 (+2)

0.94% more ownership

Funds ownership: 55.6% → 56.54% (+0.94%)

5% less capital invested

Capital invested by funds: $110M → $104M (-$5.98M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
61
Holders Change
+2
Holders Change %
+3.39%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
8
Increased
28
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$5.02M
2
Renaissance Technologies
Renaissance Technologies
New York
+$921K
3
BlackRock
BlackRock
New York
+$823K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$386K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$350K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$1.34M
2
BI
BVF Inc
California
-$1.02M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$773K
4
AG
Artal Group
Luxembourg
-$431K
5
DCM
DAFNA Capital Management
California
-$418K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$363K +$5.94K +551 +1%
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$308K – – –
Goldman Sachs
28
Goldman Sachs
New York
$303K +$191K +17,740 +128%
Stifel Financial
29
Stifel Financial
Missouri
$289K +$184K +17,078 +132%
Charles Schwab
30
Charles Schwab
California
$262K – – –
Wells Fargo
31
Wells Fargo
California
$189K +$25.4K +2,351 +14%
Two Sigma Investments
32
Two Sigma Investments
New York
$181K +$203K +18,828 New
Bank of America
33
Bank of America
North Carolina
$175K +$35.1K +3,253 +22%
Squarepoint
34
Squarepoint
New York
$173K +$194K +18,003 New
IWM
35
IHT Wealth Management
Illinois
$168K -$10.8K -1,000 -5%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$163K – – –
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$159K – – –
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$159K +$4.71K +437 +3%
Morgan Stanley
39
Morgan Stanley
New York
$159K +$133K +12,345 +293%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$148K +$3.72K +345 +2%
DADC
41
D.A. Davidson & Co
Montana
$144K +$32.4K +3,000 +25%
UBS Group
42
UBS Group
Switzerland
$137K +$34.7K +3,216 +29%
Janney Montgomery Scott
43
Janney Montgomery Scott
Pennsylvania
$130K +$146K +13,500 New
Millennium Management
44
Millennium Management
New York
$122K +$137K +12,682 New
Barclays
45
Barclays
United Kingdom
$109K +$63.1K +5,853 +106%
PPA
46
Parametric Portfolio Associates
Washington
$97K +$108K +10,053 New
Deutsche Bank
47
Deutsche Bank
Germany
$76K +$54.4K +5,045 +175%
AIG
48
American International Group
New York
$67K +$1.24K +115 +2%
Russell Investments Group
49
Russell Investments Group
United Kingdom
$55K +$63.3K +5,868 New
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$26.8K +$14.6K +1,353 +94%
1
2
3

SPRO Hedge Fund Activity: Q4 2019 in Review

61 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spero Therapeutics (SPRO) for Q4 2019, worth a combined $104M — down 5.4% from $110M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SPRO positions and 6 closed out — a net gain of 2 holders — while 28 added to existing stakes and 11 trimmed.

The largest buyer was Novo Holdings A/S, adding an estimated $5.02M. The largest seller was AWM Investment Company, cutting an estimated $1.34M.

  • 61 institutional investors held Spero Therapeutics (SPRO) as of Q4 2019, up from 59 in Q3 2019.
  • Funds reported $104M of Spero Therapeutics stock for Q4 2019, down 5.4% quarter-over-quarter.
  • 8 funds opened new Spero Therapeutics positions in Q4 2019 and 6 closed out, a net change of +2 holders.
  • The largest Spero Therapeutics buyer in Q4 2019 was Novo Holdings A/S, an estimated $5.02M added.
  • The largest Spero Therapeutics seller in Q4 2019 was AWM Investment Company, an estimated $1.34M sold.

Based on aggregated 13F filings for Q4 2019.